226 related articles for article (PubMed ID: 23017736)
1. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet.
Zhang YK; Wu KC; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2012 Nov; 264(3):305-14. PubMed ID: 23017736
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.
Chartoumpekis DV; Ziros PG; Psyrogiannis AI; Papavassiliou AG; Kyriazopoulou VE; Sykiotis GP; Habeos IG
Diabetes; 2011 Oct; 60(10):2465-73. PubMed ID: 21852674
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
[TBL] [Abstract][Full Text] [Related]
7. Keap1/Nrf2 pathway activation leads to a repressed hepatic gluconeogenic and lipogenic program in mice on a high-fat diet.
Slocum SL; Skoko JJ; Wakabayashi N; Aja S; Yamamoto M; Kensler TW; Chartoumpekis DV
Arch Biochem Biophys; 2016 Feb; 591():57-65. PubMed ID: 26701603
[TBL] [Abstract][Full Text] [Related]
8. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
9. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
Reisman SA; Csanaky IL; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 May; 109(1):31-40. PubMed ID: 19246624
[TBL] [Abstract][Full Text] [Related]
10. Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding.
More VR; Xu J; Shimpi PC; Belgrave C; Luyendyk JP; Yamamoto M; Slitt AL
Free Radic Biol Med; 2013 Aug; 61():85-94. PubMed ID: 23507082
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated expression of fatty acid oxidation enzymes and iron-regulatory genes in livers of Nrf2-null mice.
Tanaka Y; Ikeda T; Yamamoto K; Ogawa H; Kamisako T
J Gastroenterol Hepatol; 2012 Nov; 27(11):1711-7. PubMed ID: 22591204
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 protects against furosemide-induced hepatotoxicity.
Qu Q; Liu J; Zhou HH; Klaassen CD
Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.
Aleksunes LM; Reisman SA; Yeager RL; Goedken MJ; Klaassen CD
J Pharmacol Exp Ther; 2010 Apr; 333(1):140-51. PubMed ID: 20086057
[TBL] [Abstract][Full Text] [Related]
14. The Keap1-Nrf2 system prevents onset of diabetes mellitus.
Uruno A; Furusawa Y; Yagishita Y; Fukutomi T; Muramatsu H; Negishi T; Sugawara A; Kensler TW; Yamamoto M
Mol Cell Biol; 2013 Aug; 33(15):2996-3010. PubMed ID: 23716596
[TBL] [Abstract][Full Text] [Related]
15. Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice.
Zhang YK; Wu KC; Klaassen CD
PLoS One; 2013; 8(3):e59122. PubMed ID: 23527105
[TBL] [Abstract][Full Text] [Related]
16. Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissue.
Xu J; Donepudi AC; Moscovitz JE; Slitt AL
PLoS One; 2013; 8(11):e79841. PubMed ID: 24224011
[TBL] [Abstract][Full Text] [Related]
17. Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
Brachs S; Winkel AF; Polack J; Tang H; Brachs M; Margerie D; Brunner B; Jahn-Hofmann K; Ruetten H; Spranger J; Schmoll D
PLoS One; 2016; 11(11):e0166110. PubMed ID: 27814396
[TBL] [Abstract][Full Text] [Related]
18. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia.
Ungvari Z; Bailey-Downs L; Gautam T; Jimenez R; Losonczy G; Zhang C; Ballabh P; Recchia FA; Wilkerson DC; Sonntag WE; Pearson K; de Cabo R; Csiszar A
Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1133-40. PubMed ID: 21217061
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice.
Yagishita Y; Fukutomi T; Sugawara A; Kawamura H; Takahashi T; Pi J; Uruno A; Yamamoto M
Diabetes; 2014 Feb; 63(2):605-18. PubMed ID: 24186865
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet.
Hao L; Huang KH; Ito K; Sae-Tan S; Lambert JD; Ross AC
J Nutr; 2016 Feb; 146(2):184-90. PubMed ID: 26764334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
